KLRK1 and neoplasm: In another study, NKG2D-specific CAR-NK cells modified with CXCR1 demonstrated enhanced in vitro migration into tumor supernatants and increased tumor infiltration in vivo in human subcutaneous and intraperitoneal ovarian cancer xenograft models [232].